Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Enzyme mixed inhibitors

Diacylglycerol has long been known to be a weak competitive inhibitor of PLC/fc, whereas phosphorylcholine shows very little inhibition [40, 49, 116]. Recent kinetic assays of PLCB(. activity in the presence of DAG indicate that it is a competitive inhibitor with a Kl of the order of 10 mM, whereas phosphorylcholine was found to be an extremely weak (K = 30-50 mM), mixed inhibitor of PLC/J( [34]. Because diacylglycerol is a competitive inhibitor of the enzyme, the nature of the catalytic cycle dictates that it must be the last product to leave the enzyme active site. [Pg.162]

In partial (hyperbohc) mixed inhibition (O Figure 4-12d), binding of inhibitor to a site distinct from the active site results in altered affinity of enzyme for substrate (by a factor, ot) as well as a change (by a factor, /i) in the rate at which product can be released from ESI. The effects of a partial mixed inhibitor on a Lineweaver-Burk plot depend upon the actual values, and on the relative values, of ot and fl. Once again, inhibitor plots can intersect the control plot above or below, but not on, the oeaxis, and to the left or to the right of, but not on, the y-axis. Because Vmax cannot be driven to zero, a maximum Lineweaver-Burk slope is reached at infinitely high inhibitor concentrations beyond which no further increase occurs. [Pg.123]

Full and partial mixed inhibitory mechanisms, (a) Reaction scheme for full mixed inhibition indicates binding of substrate and inhibitor to two mutually exclusive sites. The presence of inhibitor prevents release of product and alters the affinity of enzyme for substrate to the same degree a) that the affinity of enzyme for inhibitor is altered by the presence of substrate, (b) Lineweaver-Burk plot for full mixed inhibition reveals a common intercept at a point which does not lie on either axis. In this example, /Cj = 3 iulM and a = 2. (c) Replot of Lineweaver-Burk slopes from (b) is linear, confirming a full inhibitory mechanism, (d) Reaction scheme for partial mixed inhibition indicates binding of substrate and inhibitor to two mutually exclusive sites. The presence of inhibitor alters the rate of release of product by a factor and the affinity of enzyme for substrate by a factor a, while the presence of substrate alters the affinity of enzyme for inhibitor by a. (e) Lineweaver-Burk plot for partial mixed inhibition reveals a common intercept at a point that does not lie on either axis. In this example, K, = 3 juiM, a = 4 and p = 0.5. (f) Replot of Lineweaver-Burk slopes from (e) is hyperbolic, confirming a partial inhibitory mechanism... [Pg.124]

Flavonoids, especially flavones and flavonols, also directly bind to several CYP isoforms (lAl, 1A2, IBl, 3A4) involved in xenobiotics metabolism and inhibit enzyme activity. Structure-activity relationships show rather high isoform selectivities depending on the flavonoid substitution pattern and contrasted inhibition mechanisms. For instance, inhibition by flavonoids of 7-methoxyresorufin O-demethylation in microsomes enriched in CYP lAl and 1A2 reveals that galangin (3,5,7-trihydroxyflavone) is a mixed inhibitor of CYP 1A2 (.ST = 8 nM) and a five times less potent inhibitor of CYP 1A1. By contrast, 7-hydroxy flavone is a competitive inhibitor of CYP lAl (Aii = 15 nM) and a six times less potent inhibitor of CYP 1A2. In addition, fairly selective inhibition of CYP IBl (specifically detected in cancer cells) by some flavonoids has been reported. For example, 5,7-dihydroxy-4 -methoxyflavone inhibits IBl, 1 Al, and 1A2 with IC50 values of 7, 80, and 80 nM, respectively. ... [Pg.461]

FIGURE 6-15 Three types of reversible inhibition, (a) Competitive inhibitors bind to the enzyme s active site, (b) Uncompetitive inhibitors bind at a separate site, blit bind only to the ES complex. K, is the equilibrium constant for inhibitor binding to E K is the equilibrium constant for inhibitor binding to ES. (c) Mixed inhibitors bind at a separate site, but may bind to either E or ES. [Pg.209]

Reversible inhibition of an enzyme is competitive, uncompetitive, or mixed. Competitive inhibitors compete with substrate by binding reversibly to the active site, but they are not transformed by the enzyme. Uncompetitive inhibitors bind only to the ES complex, at a site distinct from the active site. Mixed inhibitors bind to either E or ES, again at a site distinct from the active site. In irreversible inhibition an inhibitor binds permanently to an active site by forming a covalent bond or a veiy stable noncovalent interaction. [Pg.213]

Mix a proteinase-containing protein sample with 0.1 vol class- or enzyme-specific inhibitor solution. Include samples without inhibitor but with an appropriate amount of solvent used to prepare inhibitors, as well as known proteinases with their inhibitors as controls. [Pg.175]

These were differently affected by different procedures. For example, when the enzyme was activated at 55°, the increment in ki was slight, but k2 increased 3.5-fold. Similarly, in the presence of EDTA, fc, and k2 values decreased independently, suggesting that the sites for both activities were different. Center and Behai (5) found that with the P. mirabilis enzyme, cyclic 2, 3 -UMP competitively inhibited the hydrolysis of bis(p-nitrophenyl) phosphate. The Ki was 40 pAf very close to the Km for the cyclic nucleotide (Km, 75 yM) which indicated that the two compounds could serve as alternate substrates being hydrolyzed at the same active site. In contrast, 3 -AMP was a mixed inhibitor of cyclic 2, 3 -UMP and bis(p-nitrophenyl) phosphate hydrolysis. Adenosine was a mixed inhibitor of bis(p-nitrophenyl) phosphate hydrolysis but a competitive inhibitor of 3 -AMP hydrolysis. From such kinetic studies Center and Behai (5) suggested that two separate and adjacent sites A and B are involved in the hydrolysis of the diester and phos-phomonoester substrates. Site A serves as a binding site for hydrolysis of ribonucleoside 2, 3 -cyclic phosphates and together with site B catalyzes the hydrolysis of the diester bond. During this reaction 3 -... [Pg.360]

In this case, Kt is known as the inhibitor constant and the equilibrium between enzyme and inhibitor is almost instantaneous on mixing as 9t0 = k2 ES (the rate or reaction) is directly dependent on the concentration of the enzyme-substrate complex. The total enzyme present in the present of the inhibitor will be ... [Pg.422]

Owing to the complementary roles of NEP and APN in enkephalin inactivation, selective inhibitor of only one of the two peptidases gives weak antinoceptive effects even after ICV administration. This led us to propose the concept of mixed inhibitors, that is, compounds able to simultaneously block NEP and APN activities [reviews in 9,20]. This was possible owing to the fact that these two membrane-bound enzymes belong to the superfamily of zinc metallopeptidases. [Pg.280]

Answer The graph gives us several pieces of information. First, the inhibitor prevents the enzyme from achieving the same Fmax as in the absence of inhibitor. Second, the overall shape of the two curves is very similar at any [S] the ratio of the two velocities ( inhibitor) is the same. Third, the velocity does not change very much above [S] = 1 mM, so at much higher [S] the observed velocity is essentially Vmax for each curve. Fourth, if we estimate the [S] at which -2-Fmax is achieved, this value is nearly identical for both curves. Noncompetitive inhibition, a special form of mixed inhibition that is rarely observed, alters the Fmax of enzymes but leaves Km unchanged. Thus, acetazolamide acts as a noncompetitive (mixed) inhibitor of carbonic anhydrase. [Pg.73]

As for deaminase, the kinetic analysis suggests a partial mixed-type inhibition mechanism. Both the Ki value of the inhibitor and the breakdown rate of the enzyme-substrate-inhibitor complex are dependent on the chain length of the PolyP, thus suggesting that the breakdown rate of the enzyme-substrate-inhibitor complex is regulated by the binding of Polyphosphate to a specific inhibitory site (Yoshino and Murakami, 1988). More complicated interactions were observed between PolyP and two oxidases, i.e. spermidine oxidase of soybeen seedling and bovine serum amine oxidase. PolyP competitively inhibits the activities of both enzymes, but may serve as an regulator because the amino oxydases are also active with the polyamine-PolyP complexes (Di Paolo et al., 1995). [Pg.106]

Studies of peptidase inhibitors in brain slices indicate the importance of inhibiting both enzymes in order to significantly increase the concentrations of the endogenous opioid peptides (see Refs. 973-976). Thus, inhibiting NEP with thiorphan decreases the formation of [ H]Tyr-Gly-Gly from [ H]Met-enkephalin, but increases the production of [ H]Tyr, whereas the opposite results were found with the APN inhibitor bestatin. Both APN and NEP, as well as the other enzymes involved in enkephalin metabolism, are zinc metallopep-tidases. Thus it is possible to design mixed inhibitors capable of blocking multiple enzymes that more effectively protect the opioid peptides from metabolism (see below). [Pg.441]

An important principle, much neglected, is that the conformation of a potential inhibitor in solution is also relevant. The observed inhibition constant is a measure of fhe free energy change in fhe whole system on mixing enzyme and inhibitor. It is very unfavorable if fhe inhibitor prefers a conformation in solution of substantially lower energy fhan when bound to fhe enzyme. [Pg.172]

M. Meldal, I. Svendsen. Direct visualization of enzyme inhibitors using a portion mixing inhibitor library containing a quenched fluorogcnic peptide substrate. 1 Inhibitors for subtilisin Carlsberg. J. Chem. Soc., Perkin Trans. 1 1995, 1591-1596. [Pg.315]

Mechanisms of CYP inhibition can be broadly divided into two categories reversible inhibition and mechanism-based inactivation. Depending on the mode of interaction between CYP enzymes and inhibitors, reversible CYP inhibition is further characterized as competitive, noncompetitive, uncompetitive, and mixed (Ito et al., 1998b). Evaluation of reversible inhibition of CYP reactions is often conducted under conditions where M-M kinetics is obeyed. Based on the scheme illustrated in Fig. 5.1, various types of reversible inhibition are summarized in Table 5.1. Figure 5.1 depicts a simple substrate-enzyme complex during catalysis. In the presence of a reversible inhibitor, such a complex can be disrupted leading to enzyme inhibition. [Pg.114]

May be most inhibitors are mixed-type however competitive and non-competitive behaviors are frequently reported when one effect is significantly stronger than the other. Mixed-type inhibition, as non-competitive inhibition, can be partial or total depending on the activity of the tertiary enzyme-substrate-inhibitor complex. A particular case of mixed-type inhibition is uncompetitive inhibition in this case the enzyme has no preformed site for binding the inhibitor, that can only binds to the enzyme after the substrate has bound to it. This situation is not frequent, with the exception of the case when the substrate itself is the inhibitor in fact, uncompetitive inhibition by high substrate concentration is rather common in enzyme catalyzed reactions. [Pg.117]

Although enzyme reactions are highly specific, inhibition of the enzymes do occur. Inhibitors, substances that decrease the rate of an enzyme-catalyzed reaction, are classified as competitive, noncompetitive, uncompetitive, or mixed [4]. Each type can be characterized by deviation from the Lineweaver-Burk plot of the corresponding uninhibited reaction. Competitive inhibitors compete for the active sites with the substrate and slow down the enzyme reaction they increase Km but have no affect on Vmax- Noncompetitive inhibitors bind reversibly to the enzyme at a site different from the active site, but one that is necessary for the enzyme action. These inhibitors decrease Emax, but Km is unaffected. Uncompetitive inhibitors are known to bind reversibly to the enzyme-substrate complex to form an inactive enzyme-substrate-inhibitor complex. A decrease in Km and max by the same factor is observed (i.e., the Lineweaver-Burk plot is parallel to the plot of the uninhibited reaction). In mixed-type inhibitors, more than one of the foregoing mechanisms operate, and Km and Lmax values are both altered. [Pg.503]


See other pages where Enzyme mixed inhibitors is mentioned: [Pg.146]    [Pg.191]    [Pg.100]    [Pg.169]    [Pg.423]    [Pg.114]    [Pg.123]    [Pg.1494]    [Pg.120]    [Pg.226]    [Pg.249]    [Pg.280]    [Pg.46]    [Pg.163]    [Pg.442]    [Pg.443]    [Pg.303]    [Pg.286]    [Pg.441]    [Pg.441]    [Pg.226]    [Pg.202]    [Pg.163]    [Pg.1139]    [Pg.320]    [Pg.116]    [Pg.30]   
See also in sourсe #XX -- [ Pg.317 ]




SEARCH



Enzyme inhibitors

Enzymes enzyme inhibitor

© 2024 chempedia.info